CircuLite is a cardiovascular device company that is transforming heart failure treatment with the development of minimally-invasive micro-pumps for long term partial circulatory support (PCS). By enabling a proactive and lower-risk treatment approach by supplementing a patient's native pumping capacity, CircuLite has the potential to improve the quality of life for millions of chronic heart failure patients and their families. CircuLite's pipeline of PCS devices is lead by the Synergyâ„¢ Pocket Micro-Pump System, a surgically implanted micro-pump currently in a CE Mark clinical trial. Next-generation Synergy micro-pumps include an endovascular system, a fully-implantable system and a pediatric system.
04/07/2008 - CircuLite Synergyâ„¢ to be highlighted at ISHLT
03/06/2008 - CircuLite Announces Initiation of European Registration Study
02/21/2008 - CircuLite Reports Preliminary Results of First-In-Man Pilot Study